TITLE

Stem-cell pioneer banks on future therapies

AUTHOR(S)
Cyranoski, David
PUB. DATE
August 2012
SOURCE
Nature;8/9/2012, Vol. 488 Issue 7410, p139
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article focuses on the plans of Shinya Yamanaka of Kyoto University to build stem cell bank to be used for therapeutic purposes. It says that the scheme called the Induced Pluripotent Stem (iPS) Cell Stock, gained support from the country's health ministry committee. It mentions various efforts of the country to move iPS cell therapies to the clinic such as the project to relieve Parkinson's disease worth 2.5 million dollars a year and the human clinical trial involving iPS cells.
ACCESSION #
78362013

 

Related Articles

  • One Japan Stem Cell Institute Soars, One Struggles. Fox, Cynthia // Bioscience Technology;Jun2014, p1 

    The article reports on Center for iPS Cell Research and Application (CiRA) Nobel Prize winner and scientist Shinya Yamanaka in Japan. It mentions his statement over their proposed clinical trials on induced pluripotent stem cells (IPSCs). It also notes the problem of his sister institute, the...

  • Japan stem-cell trial stirs envy. Reardon, Sara; Cyranoski, David // Nature;9/18/2014, Vol. 513 Issue 7518, p287 

    The article discusses the clinical trials of induced pluripotent stem (iPS) cells. It states that the iPS cells are created by using a patient's own tissue and by inserting them in an adult's DNA cells to reprogram the cells to an embryonic-like state. The therapy was pioneered by Shinya...

  • Induced Pluripotent Stem Cells. Wilson, Kitchener D.; Wu, Joseph C. // JAMA: Journal of the American Medical Association;4/28/2015, Vol. 313 Issue 16, p1613 

    The article discusses the 2006 discovery of a method for creating induced pluripotent stem cells (iPSCs) by Takahashi and Shinya Yamanaka and colleagues, which won Yamanaka a Nobel Prize in 2012. Topics include the use of pluripotency to regenerate human organs and tissues, the time consumption...

  • Induced pluripotent stem cells for spinal cord injury therapy: current status and perspective. Wang, H.; Fang, H.; Dai, J.; Liu, G.; Xu, Z. // Neurological Sciences;Jan2013, Vol. 34 Issue 1, p11 

    Spinal cord injury (SCI) is induced by a variety of damages such as trauma, ischemia, and iatrogenic injury, resulting in sense and motion dysfunction. Despite the improvements in medical and surgical care, current treatment methods for SCI demonstrate poor and delayed efficiency, leading to...

  • Simple recipe gives adult cells embryonic powers. Check, Erika // Nature;7/6/2006, Vol. 442 Issue 7098, p11 

    The article reports that Shinya Yamanaka and his colleagues at Kyoto University in Kyoto, Japan have developed a chemical recipe that can program adult mouse cells into an embryonic state to repair damaged tissues or organs. They said that it takes only four chemicals to program the cells. When...

  • REWIND STEM CELLS, THEN FAST FORWARD. Coghlan, Andy // New Scientist;12/22/2012, Vol. 216 Issue 2896/2897, p21 

    The article discusses the development of a process to transform adult cells into a stem cell state, focusing on induced pluripotent stem cells reverted by the researcher Shinya Yamanaka and a clinical trial planned by the biotechnology company Advanced Cell Technology Inc.

  • Catalent, CiRA In Regenerative Therapy Pact.  // Contract Pharma;Apr2014, Vol. 16 Issue 3, p34 

    The article reports that pharmaceutical company Catalent Pharma Solutions has formed a deal with Kyoto University's Center for iPS Cell Research and Application (CiRA) in Japan to advance human therapies using induced pluripotent stem (iPS) cells.

  • Ahead of the Curve. Walsh, Bryan; Oda, Yuki; Sekiguchi, Toko // Time International (South Pacific Edition);6/25/2007, Issue 24, p38 

    This article introduces Japanese researcher Shinya Yamanaka from Kyoto University in Kyoto, Japan. The article discusses Yamanaka’s research while explaining how he was able to genetically reprogram the skin cell from a mouse to revert back into the equivalent of its embryonic state. The...

  • IPSCs: One cell to rule them all? Eisenstein, Michael // Nature Methods;Jan2010, Vol. 7 Issue 1, p81 

    The article reports on the developments made in embryonic stem cells (ESCs) into induced pluripotent stem cells (iPSCs) by scientist Shinya Yamanaka and his team at Kyoto University in Japan. As reported, iPSCs were formed by reprogramming the adult mouse fibroblasts, that is aimed at targeting...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics